Yoland C Antill

8PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAudiologyPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 01, 2025
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial.

Kenichi Harano, Roldano Fossati, Beatriz Pardo

|Oct 21, 2024
Impact of chemotherapy on patients with mismatch repair deficient advanced endometrial carcinomas-a meta-analysis.

Angelina Tjokrowidjaja, Peey-Sei Kok, Yoland C Antill

|Jan 08, 2023
Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA).

Deborah Smith, Kristy P Robledo, Sonia Yip

|Aug 30, 2021
The role of depression and other psychological factors in work ability among breast cancer survivors in Australia.

Seon-Young Kim, David W Kissane, Gary Richardson

|Jun 09, 2021
Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial.

Yoland Antill, Peey-Sei Kok, Kristy Robledo

|Jul 23, 2019
PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression.

Peey Sei Kok, Philip Beale, Rachel L O'Connell

Pageof 2

Frequent Collaborators

3 joint publications

Peey-Sei Kok

2 joint publications

Yeh Chen Lee

1 joint publications

Philip Beale

1 joint publications

Rachel L O'Connell